MedBud has been incorporated as a non-profit organisation, with Dr. Tahzid Ahsan (Specialist Psychiatrist) joining as medical director Announcement on X/Twitter

Back to Khiron or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Strain Estimate)

CaryophylleneMajorPepper/Spice119℃
LinaloolMajorFloral/Spice198℃
HumuleneMajorWoody/Earthy107℃

MedBud currently tracks 16 common terpenes, more will be added.

No official terpene profile has been provided for this product, information above is estimated based on public strain information.

Dosing Look-Up Table (Estimated)

0.01/g0.5/mg THC0.7/mg CBD
0.05/g2.5/mg THC3.5/mg CBD
0.1/g5/mg THC7/mg CBD
0.15/g7.5/mg THC10.5/mg CBD
0.2/g10/mg THC14/mg CBD
0.25/g12.5/mg THC17.5/mg CBD
0.3/g15/mg THC21/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Flag of Colombia Khiron
Designation
T5:C7
Cultivar/Strain
Caramel CBD
Classification
Hybrid
Chemotype
Type II: THC/CBD Mix
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
4.5-5.5%
CBD Potential Range (±10%)
7%
Cultivated/Produced by
Flag of Columbia Khiron Med
Cultivated or Packaged in
Flag of Portugal Portugal
Irradiation
Non-Irradiated
Imported by
United Kingdom IPS Pharma
Imported as
Schedule II: Finished Product

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Discontinued

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Project Twenty21

Available on T21, a research project offering participating patients several discounted medications:

Participating Pharmacies:
Product DescriptionPatient Reviews

About Caramel CBD

CarHybrid

The taste and aroma of CBD Caramel are all in the name; expect sweet and spicy flavors to hit the senses.

Dutch Flag Dutch Bred, Indian Flag Indian Genetics, Afghani Flag Afghani Genetics

CBD Caramel derives from the cross of a Brazilian, a Himalayan, an Afghan and an unknown CBD enriched cannabis strain. The result is just perfect for therapeutic use. With a 1:1 THC-CBD ratio, she is sure to please. The taste and aroma of CBD Caramel are all in the name; expect sweet and spicy flavors to hit the senses. Thanks to the balanced cannabinoid ratio, the psychoactive high delivered is pleasantly subtle and won't lock you into a body stone too heavily. It makes this cannabis strain well suited to both day and evening use, when you need to stay functional but want a nice buzz.

CBD Caramel is ideal for growing in humid climates but can do well just about anywhere that doesn't get too cold. She has a flowering time of 8-9 weeks indoors and can produce 450-550g/m² under ideal conditions. Outdoors, she is ready for harvest towards the end of September, usually producing around 450g/plant when treated just right.

Description provided by CannaConnection.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

Flag of Colombia About Khiron Life Sciences Corp

Khiron Logo

Founded in October 2019, working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.

Khiron Life Sciences UK was founded in October 2019 and has been working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.

Putting our patients first is what allowed Khiron Life Sciences to become the medical cannabis market leader in Latin America.

Our team is composed of experienced professionals from of the European medical cannabis industry. We are working closely with the London-based leading independent scientific body, Drug Science, responsible for Project Twenty21, the largest medical cannabis patient registry in Europe.

khironmed.co.uk

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)